FDA Advisory Panel Review of Guardant Health's Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23 : vimarsana.com

Guardant Health, Inc. , a leading precision oncology company, today announced the Molecular and Clinical Genetics Panel of the U.S. Food and Drug Administration Medical Devices Advisory Committee is...

Related Keywords

Amirali Talasaz , Facebook , Nasdaq , Guardant Health Inc , Guardant Health , Linkedin , Drug Administration Medical Devices Advisory Committee , Advisory Committee , Clinical Genetics Panel , Exchange Commission , Financial Condition , Annual Report , Markets ,